{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:00:02Z","timestamp":1777471202969,"version":"3.51.4"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,11,18]],"date-time":"2015-11-18T00:00:00Z","timestamp":1447804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,11,18]],"date-time":"2015-11-18T00:00:00Z","timestamp":1447804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Graves\u2019 ophthalmopathy (GO) is the commonest extra-thyroidal manifestation of Graves\u2019 disease (GD). Associations between interleukin-related (IL) gene polymorphisms and GO have been reported in different populations. We aim to confirm such associations by conducting a meta-analysis. Totally 382 publications were retrieved in MEDLINE and EMBASE up to 25\/2\/2015. After removing the duplicates and assessing the studies, we retrieved 16 studies that met the selection criteria for meta-analysis, involving 12 polymorphisms in 8 IL-related genes and 1650 GO cases and 2909 GD controls. The summary odds ratio (OR) and 95% confidence intervals (CI) were estimated. We found one polymorphism in <jats:italic>IL1A<\/jats:italic> (rs1800587, c.-889C&gt;T) showing a suggestive association with GO in the meta-analysis (allelic model [T vs. C]: OR\u2009=\u20091.62, 95% CI: 1.00\u20132.62, P\u2009=\u20090.050, <jats:italic>I<\/jats:italic><jats:sup><jats:italic>2<\/jats:italic><\/jats:sup>\u2009=\u200953.7%; recessive model [TT vs. TC\u2009+\u2009CC]: OR\u2009=\u20092.39, 95% CI: 1.07\u20135.37, P\u2009=\u20090.039, <jats:italic>I<\/jats:italic><jats:sup><jats:italic>2<\/jats:italic><\/jats:sup>\u2009=\u200923.6%; heterozygous model [TC vs. CC]: OR\u2009=\u20091.52, 95% CI: 1.04\u20132.22, P\u2009=\u20090.034, <jats:italic>I<\/jats:italic><jats:sup><jats:italic>2<\/jats:italic><\/jats:sup>\u2009=\u200937.0%). No association with GO was detected for the other 7 genes (<jats:italic>IL1B<\/jats:italic>, <jats:italic>IL1RA<\/jats:italic>, <jats:italic>IL4<\/jats:italic>, <jats:italic>IL6<\/jats:italic>, <jats:italic>IL12B<\/jats:italic>, <jats:italic>IL13<\/jats:italic> and <jats:italic>IL23R<\/jats:italic>). Our results thus indicate that <jats:italic>IL1A<\/jats:italic> is likely to be a genetic biomarker for GO. Further studies with larger sample sizes are warranted to confirm the associations of <jats:italic>IL1A<\/jats:italic> and other IL-related genes with GO.<\/jats:p>","DOI":"10.1038\/srep16672","type":"journal-article","created":{"date-parts":[[2015,11,18]],"date-time":"2015-11-18T10:28:01Z","timestamp":1447842481000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Genetic Associations of Interleukin-related Genes with Graves\u2019 Ophthalmopathy: a Systematic Review and Meta-analysis"],"prefix":"10.1038","volume":"5","author":[{"given":"Kah Hie","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi Song","family":"Rong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelvin K. L.","family":"Chong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alvin L.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi Pui","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li Jia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,11,18]]},"reference":[{"key":"BFsrep16672_CR1","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJM199311113292007","volume":"329","author":"RS Bahn","year":"1993","unstructured":"Bahn, R. S. & Heufelder, A. E. Pathogenesis of Graves\u2019 ophthalmopathy. N Engl J Med 329, 1468\u20131475 (1993).","journal-title":"N Engl J Med"},{"key":"BFsrep16672_CR2","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1210\/jc.2012-3873","volume":"98","author":"ML Tanda","year":"2013","unstructured":"Tanda, M. L. et al. Prevalence and natural history of Graves\u2019 orbitopathy in a large series of patients with newly diagnosed graves\u2019 hyperthyroidism seen at a single center. J Clin Endocrinol Metab 98, 1443\u20131449 (2013).","journal-title":"J Clin Endocrinol Metab"},{"key":"BFsrep16672_CR3","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1089\/105072502761016476","volume":"12","author":"WM Wiersinga","year":"2002","unstructured":"Wiersinga, W. M. & Bartalena, L. Epidemiology and prevention of Graves\u2019 ophthalmopathy. Thyroid 12, 855\u2013860 (2002).","journal-title":"Thyroid"},{"key":"BFsrep16672_CR4","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","volume":"362","author":"RS Bahn","year":"2010","unstructured":"Bahn, R. S. Graves\u2019 ophthalmopathy. N Engl J Med 362, 726\u2013738 (2010).","journal-title":"N Engl J Med"},{"key":"BFsrep16672_CR5","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1210\/er.2002-0030","volume":"24","author":"Y Tomer","year":"2003","unstructured":"Tomer, Y. & Davies, T. F. Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr Rev 24, 694\u2013717 (2003).","journal-title":"Endocr Rev"},{"key":"BFsrep16672_CR6","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/BF03346614","volume":"33","author":"TJ Smith","year":"2010","unstructured":"Smith, T. J. Pathogenesis of Graves\u2019 orbitopathy: a 2010 update. J Endocrinol Invest 33, 414\u2013421 (2010).","journal-title":"J Endocrinol Invest"},{"key":"BFsrep16672_CR7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/thy.1992.2.299","volume":"2","author":"Y Hiromatsu","year":"1992","unstructured":"Hiromatsu, Y. et al. Role of magnetic resonance imaging in thyroid-associated ophthalmopathy: its predictive value for therapeutic outcome of immunosuppressive therapy. Thyroid 2, 299\u2013305 (1992).","journal-title":"Thyroid"},{"key":"BFsrep16672_CR8","first-page":"222","volume":"75","author":"AP Weetman","year":"1989","unstructured":"Weetman, A. P., Cohen, S., Gatter, K. C., Fells, P. & Shine, B. Immunohistochemical analysis of the retrobulbar tissues in Graves\u2019 ophthalmopathy. Clin Exp Immunol 75, 222\u2013227 (1989).","journal-title":"Clin Exp Immunol"},{"key":"BFsrep16672_CR9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/clin.1994.1169","volume":"73","author":"G Kahaly","year":"1994","unstructured":"Kahaly, G., Hansen, C., Felke, B. & Dienes, H. P. Immunohistochemical staining of retrobulbar adipose tissue in Graves\u2019 ophthalmopathy. Clin Immunol Immunopathol 73, 53\u201362 (1994).","journal-title":"Clin Immunol Immunopathol"},{"key":"BFsrep16672_CR10","first-page":"685","volume":"80","author":"Y Hiromatsu","year":"1995","unstructured":"Hiromatsu, Y. et al. Human histocompatibility leukocyte antigen-DR and heat shock protein-70 expression in eye muscle tissue in thyroid-associated ophthalmopathy. J Clin Endocrinol Metab 80, 685\u2013691 (1995).","journal-title":"J Clin Endocrinol Metab"},{"key":"BFsrep16672_CR11","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1210\/jc.2013-1245","volume":"98","author":"B Li","year":"2013","unstructured":"Li, B. & Smith, T. J. Divergent expression of IL-1 receptor antagonists in CD34+ fibrocytes and orbital fibroblasts in thyroid-associated ophthalmopathy: contribution of fibrocytes to orbital inflammation. J Clin Endocrinol Metab 98, 2783\u20132790 (2013).","journal-title":"J Clin Endocrinol Metab"},{"key":"BFsrep16672_CR12","first-page":"1194","volume":"85","author":"Y Hiromatsu","year":"2000","unstructured":"Hiromatsu, Y. et al. Cytokine profiles in eye muscle tissue and orbital fat tissue from patients with thyroid-associated ophthalmopathy. J Clin Endocrinol Metab 85, 1194\u20131199 (2000).","journal-title":"J Clin Endocrinol Metab"},{"key":"BFsrep16672_CR13","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1210\/jc.2003-030380","volume":"88","author":"S Kumar","year":"2003","unstructured":"Kumar, S. & Bahn, R. S. Relative overexpression of macrophage-derived cytokines in orbital adipose tissue from patients with graves\u2019 ophthalmopathy. J Clin Endocrinol Metab 88, 4246\u20134250 (2003).","journal-title":"J Clin Endocrinol Metab"},{"key":"BFsrep16672_CR14","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s12020-012-9840-7","volume":"44","author":"K Cai","year":"2013","unstructured":"Cai, K. & Wei, R. Interleukin-7 expression in tears and orbital tissues of patients with Graves\u2019 ophthalmopathy. Endocrine 44, 140\u2013144 (2013).","journal-title":"Endocrine"},{"key":"BFsrep16672_CR15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/08916939708996275","volume":"25","author":"I Molnar","year":"1997","unstructured":"Molnar, I. & Balazs, C. High circulating IL-6 level in Graves\u2019 ophthalmopathy. Autoimmunity 25, 91\u201396 (1997).","journal-title":"Autoimmunity"},{"key":"BFsrep16672_CR16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1530\/eje.0.1430197","volume":"143","author":"M Salvi","year":"2000","unstructured":"Salvi, M. et al. Serum concentrations of proinflammatory cytokines in Graves\u2019 disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking. Eur J Endocrinol 143, 197\u2013202 (2000).","journal-title":"Eur J Endocrinol"},{"key":"BFsrep16672_CR17","first-page":"1120","volume":"77","author":"M de Carli","year":"1993","unstructured":"de Carli, M. et al. Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves\u2019 ophthalmopathy. J Clin Endocrinol Metab 77, 1120\u20131124 (1993).","journal-title":"J Clin Endocrinol Metab"},{"key":"BFsrep16672_CR18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/08916939709003857","volume":"26","author":"N Natt","year":"1997","unstructured":"Natt, N. & Bahn, R. S. Cytokines in the evolution of Graves\u2019 ophthalmopathy. Autoimmunity 26, 129\u2013136 (1997).","journal-title":"Autoimmunity"},{"key":"BFsrep16672_CR19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1210\/en.2005-1018","volume":"147","author":"R Han","year":"2006","unstructured":"Han, R. & Smith, T. J. T helper type 1 and type 2 cytokines exert divergent influence on the induction of prostaglandin E2 and hyaluronan synthesis by interleukin-1beta in orbital fibroblasts: implications for the pathogenesis of thyroid-associated ophthalmopathy. Endocrinology 147, 13\u201319 (2006).","journal-title":"Endocrinology"},{"key":"BFsrep16672_CR20","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1089\/thy.2007.0403","volume":"18","author":"V Naik","year":"2008","unstructured":"Naik, V. et al. Biologic therapeutics in thyroid-associated ophthalmopathy: translating disease mechanism into therapy. Thyroid 18, 967\u2013971 (2008).","journal-title":"Thyroid"},{"key":"BFsrep16672_CR21","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1442-9071.2009.02093.x","volume":"37","author":"O Khalilzadeh","year":"2009","unstructured":"Khalilzadeh, O. et al. Graves\u2019 ophthalmopathy and gene polymorphisms in interleukin-1alpha, interleukin-1beta, interleukin-1 receptor and interleukin-1 receptor antagonist. Clin Experiment Ophthalmol 37, 614\u2013619 (2009).","journal-title":"Clin Experiment Ophthalmol"},{"key":"BFsrep16672_CR22","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.humimm.2010.01.023","volume":"71","author":"N Liu","year":"2010","unstructured":"Liu, N. et al. The association of interleukin-1alpha and interleukin-1beta polymorphisms with the risk of Graves\u2019 disease in a case-control study and meta-analysis. Hum Immunol 71, 397\u2013401 (2010).","journal-title":"Hum Immunol"},{"key":"BFsrep16672_CR23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/02713680802699390","volume":"34","author":"K Lacka","year":"2009","unstructured":"Lacka, K. et al. Interleukin-1beta gene (IL-1beta) polymorphisms (SNP \u2212511 and SNP +3953) in thyroid-associated ophthalmopathy (TAO) among the Polish population. Curr Eye Res 34, 215\u2013220 (2009).","journal-title":"Curr Eye Res"},{"key":"BFsrep16672_CR24","doi-asserted-by":"crossref","first-page":"6238","DOI":"10.1167\/iovs.09-4965","volume":"51","author":"YH Liu","year":"2010","unstructured":"Liu, Y. H. et al. Association of interleukin-1beta (IL1B) polymorphisms with Graves\u2019 ophthalmopathy in Taiwan Chinese patients. Invest Ophthalmol Vis Sci 51, 6238\u20136246 (2010).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFsrep16672_CR25","first-page":"4476","volume":"81","author":"RM Cuddihy","year":"1996","unstructured":"Cuddihy, R. M. & Bahn, R. S. Lack of an association between alleles of interleukin-1 alpha and interleukin-1 receptor antagonist genes and Graves\u2019 disease in a North American Caucasian population. J Clin Endocrinol Metab 81, 4476\u20134478 (1996).","journal-title":"J Clin Endocrinol Metab"},{"key":"BFsrep16672_CR26","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1530\/eje.0.1380686","volume":"138","author":"T Muhlberg","year":"1998","unstructured":"Muhlberg, T. et al. Lack of association of Graves\u2019 disease with the A2 allele of the interleukin-1 receptor antagonist gene in a white European population. Eur J Endocrinol 138, 686\u2013690 (1998).","journal-title":"Eur J Endocrinol"},{"key":"BFsrep16672_CR27","first-page":"111","volume":"80","author":"AIF Blakemore","year":"1995","unstructured":"Blakemore, A. I. F., Watson, P. F., Weetman, A. P. & Duff, G. W. Association of Graves\u2019 disease with an allele of the interleukin-1 receptor antagonist gene. J Clin Endocrinol Metab 80, 111\u2013115 (1995).","journal-title":"J Clin Endocrinol Metab"},{"key":"BFsrep16672_CR28","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/eye.2009.244","volume":"24","author":"M Anvari","year":"2010","unstructured":"Anvari, M. et al. Genetic susceptibility to Graves\u2019 ophthalmopathy: the role of polymorphisms in proinflammatory cytokine genes. Eye 24, 1058\u20131063 (2010).","journal-title":"Eye"},{"key":"BFsrep16672_CR29","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/BF03346682","volume":"33","author":"W Zhu","year":"2010","unstructured":"Zhu, W. et al. Association analysis of polymorphisms in IL-3, IL-4, IL-5, IL-9 and IL-13 with Graves\u2019 disease. J Endocrinol Invest 33, 751\u2013755 (2010).","journal-title":"J Endocrinol Invest"},{"key":"BFsrep16672_CR30","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s10038-005-0297-x","volume":"50","author":"Y Yang","year":"2005","unstructured":"Yang, Y. et al. Association study between the IL4, IL13, IRF1 and UGRP1 genes in chromosomal 5q31 region and Chinese Graves\u2019 disease. J Hum Genet 50, 574\u2013582 (2005).","journal-title":"J Hum Genet"},{"key":"BFsrep16672_CR31","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/13816810.2010.515648","volume":"31","author":"O Khalilzadeh","year":"2010","unstructured":"Khalilzadeh, O. et al. Genetic susceptibility to Graves\u2019 ophthalmopathy: The role of polymorphisms in anti-inflammatory cytokine genes. Ophthalmic Genet 31, 215\u2013220 (2010).","journal-title":"Ophthalmic Genet"},{"key":"BFsrep16672_CR32","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/0891693042000193320","volume":"37","author":"T Bednarczuk","year":"2004","unstructured":"Bednarczuk, T. et al. Association of G-174C polymorphism of the interleukin-6 gene promoter with Graves\u2019 ophthalmopathy. Autoimmunity 37, 223\u2013226 (2004).","journal-title":"Autoimmunity"},{"key":"BFsrep16672_CR33","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s12020-009-9240-9","volume":"36","author":"LQ Gu","year":"2009","unstructured":"Gu, L. Q. et al. Association studies of interleukin-8 gene in Graves\u2019 disease and Graves\u2019 ophthalmopathy. Endocrine 36, 452\u2013456 (2009).","journal-title":"Endocrine"},{"key":"BFsrep16672_CR34","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1507\/endocrj.K06-040","volume":"53","author":"Y Hiromatsu","year":"2006","unstructured":"Hiromatsu, Y. et al. Interleukin-12B gene polymorphism does not confer susceptibility to Graves\u2019 ophthalmopathy in Japanese population. Endocr J 53, 753\u2013759 (2006).","journal-title":"Endocr J"},{"key":"BFsrep16672_CR35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1423-0127-19-97","volume":"19","author":"YH Liu","year":"2012","unstructured":"Liu, Y. H. et al. Association of IL12B polymorphisms with susceptibility to Graves ophthalmopathy in a Taiwan Chinese population. J Biomed Sci 19, 97 (2012).","journal-title":"J Biomed Sci"},{"key":"BFsrep16672_CR36","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1046\/j.1365-2265.2003.01880.x","volume":"59","author":"T Bednarczuk","year":"2003","unstructured":"Bednarczuk, T. et al. Interleukin-13 gene polymorphisms in patients with Graves\u2019 disease. Clin Endocrinol (Oxf) 59, 519\u2013525 (2003).","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BFsrep16672_CR37","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1210\/jc.2004-0931","volume":"90","author":"Y Hiromatsu","year":"2005","unstructured":"Hiromatsu, Y. et al. Interleukin-13 gene polymorphisms confer the susceptibility of Japanese populations to Graves\u2019 disease. J Clin Endocrinol Metab 90, 296\u2013301 (2005).","journal-title":"J Clin Endocrinol Metab"},{"key":"BFsrep16672_CR38","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1167\/iovs.07-1433","volume":"49","author":"KKL Chong","year":"2008","unstructured":"Chong, K. K. L. et al. Association of CTLA-4 and IL-13 gene polymorphisms with Graves\u2019 disease and ophthalmopathy in Chinese children. Invest Ophthalmol Vis Sci 49, 2409\u20132415 (2008).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFsrep16672_CR39","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/thy.2006.16.243","volume":"16","author":"T Mukai","year":"2006","unstructured":"Mukai, T. et al. Lack of association of interleukin-18 gene polymorphisms with susceptibility of Japanese populations to Graves\u2019 disease or Graves\u2019 ophthalmopathy. Thyroid 16, 243\u2013248 (2006).","journal-title":"Thyroid"},{"key":"BFsrep16672_CR40","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.4238\/2011.October.31.6","volume":"10","author":"HY Jia","year":"2011","unstructured":"Jia, H. Y. et al. Association between interleukin 21 and Graves\u2019 disease. Genet Mol Res 10, 3338\u20133346 (2011).","journal-title":"Genet Mol Res"},{"key":"BFsrep16672_CR41","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1210\/jc.2007-2190","volume":"93","author":"AK Huber","year":"2008","unstructured":"Huber, A. K., Jacobson, E. M., Jazdzewski, K., Concepcion, E. S. & Tomer, Y. Interleukin (IL)-23 receptor is a major susceptibility gene for Graves\u2019 ophthalmopathy: the IL-23\/T-helper 17 axis extends to thyroid autoimmunity. J Clin Endocrinol Metab 93, 1077\u20131081 (2008).","journal-title":"J Clin Endocrinol Metab"},{"key":"BFsrep16672_CR42","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/08916930802422265","volume":"42","author":"Y Ban","year":"2009","unstructured":"Ban, Y. et al. Association studies of the IL-23R gene in autoimmune thyroid disease in the Japanese population. Autoimmunity 42, 126\u2013130 (2009).","journal-title":"Autoimmunity"},{"key":"BFsrep16672_CR43","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/08916930802422265","volume":"42","author":"T Tozaki","year":"2009","unstructured":"Tozaki, T. et al. Association studies of the IL-23R gene in autoimmune thyroid disease in the Japanese population. Autoimmunity 42, 126\u2013130 (2009).","journal-title":"Autoimmunity"},{"key":"BFsrep16672_CR44","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.beem.2011.10.004","volume":"26","author":"CL Chng","year":"2012","unstructured":"Chng, C. L., Seah, L. L. & Khoo, D. H. Ethnic differences in the clinical presentation of Graves\u2019 ophthalmopathy. Best Pract Res Clin Endocrinol Metab 26, 249\u2013258 (2012).","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"BFsrep16672_CR45","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1089\/105072502753600160","volume":"12","author":"Y Hiromatsu","year":"2002","unstructured":"Hiromatsu, Y., Kaku, H., Miyake, I., Murayama, S. & Soejima, E. Role of cytokines in the pathogenesis of thyroid-associated ophthalmopathy. Thyroid 12, 217\u2013221 (2002).","journal-title":"Thyroid"},{"key":"BFsrep16672_CR46","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.gene.2014.06.038","volume":"547","author":"M Niyazoglu","year":"2014","unstructured":"Niyazoglu, M. et al. Association of PARP-1, NF-kappaB, NF-kappaBIA and IL-6, IL-1beta and TNF-alpha with Graves Disease and Graves Ophthalmopathy. Gene 547, 226\u2013232 (2014).","journal-title":"Gene"},{"key":"BFsrep16672_CR47","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2265.2007.02854.x","volume":"67","author":"T Bednarczuk","year":"2007","unstructured":"Bednarczuk, T., Gopinath, B., Ploski, R. & Wall, J. R. Susceptibility genes in Graves\u2019 ophthalmopathy: searching for a needle in a haystack? Clin Endocrinol (Oxf) 67, 3\u201319 (2007).","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BFsrep16672_CR48","doi-asserted-by":"crossref","first-page":"564","DOI":"10.2174\/138920211798120844","volume":"12","author":"O Khalilzadeh","year":"2011","unstructured":"Khalilzadeh, O., Noshad, S., Rashidi, A. & Amirzargar, A. Graves\u2019 Ophthalmopathy: A review of immunogenetics. Curr Genomics 12, 564\u2013575 (2011).","journal-title":"Curr Genomics"},{"key":"BFsrep16672_CR49","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1586\/17469899.2014.917960","volume":"9","author":"F Rajaii","year":"2014","unstructured":"Rajaii, F., McCoy, A. N. & Smith, T. J. Cytokines as villains and potential therapeutic targets in thyroid-associated ophthalmopathy: From bench to bedside. Expert Rev Ophthalmol 9, 227\u2013234 (2014).","journal-title":"Expert Rev Ophthalmol"},{"key":"BFsrep16672_CR50","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1182\/blood.V77.8.1627.1627","volume":"77","author":"CA Dinarello","year":"1991","unstructured":"Dinarello, C. A. Interleukin-1 and interleukin-1 antagonism. Blood 77, 1627\u20131652 (1991).","journal-title":"Blood"},{"key":"BFsrep16672_CR51","first-page":"203","volume":"61","author":"N Laban-Guceva","year":"2007","unstructured":"Laban-Guceva, N., Bogoev, M. & Antova, M. Serum concentrations of interleukin (IL-)1alpha, 1beta, 6 and tumor necrosis factor (TNF-) alpha in patients with thyroid eye disease (TED). Med Arh 61, 203\u2013206 (2007).","journal-title":"Med Arh"},{"key":"BFsrep16672_CR52","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2362.1993.tb00712.x","volume":"23","author":"AE Heufelder","year":"1993","unstructured":"Heufelder, A. E. & Bahn, R. S. Detection and localization of cytokine immunoreactivity in retro-ocular connective tissue in Graves\u2019 ophthalmopathy. Eur J Clin Invest 23, 10\u201317 (1993).","journal-title":"Eur J Clin Invest"},{"key":"BFsrep16672_CR53","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1530\/eje.0.1340051","volume":"134","author":"AE Heufelder","year":"1996","unstructured":"Heufelder, A. E. & Scriba, P. C. Characterization of adhesion receptors on cultured microvascular endothelial cells derived from the retroorbital connective tissue of patients with Graves\u2019 ophthalmopathy. Eur J Endocrinol 134, 51\u201360 (1996).","journal-title":"Eur J Endocrinol"},{"key":"BFsrep16672_CR54","first-page":"120","volume":"35","author":"AE Heufelder","year":"1994","unstructured":"Heufelder, A. E. & Bahn, R. S. Modulation of Graves\u2019 orbital fibroblast proliferation by cytokines and glucocorticoid receptor agonists. Invest Ophthalmol Vis Sci 35, 120\u2013127 (1994).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFsrep16672_CR55","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1055\/s-0029-1212175","volume":"107","author":"TJ Smith","year":"1999","unstructured":"Smith, T. J. The putative role of prostaglandin endoperoxide H synthase-2 in the pathogenesis of thyroid-associated orbitopathy. Exp Clin Endocrinol Diabetes 107 Suppl 5, S160\u2013163 (1999).","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"BFsrep16672_CR56","doi-asserted-by":"crossref","first-page":"C1075","DOI":"10.1152\/ajpcell.1999.277.6.C1075","volume":"277","author":"HJ Cao","year":"1999","unstructured":"Cao, H. J. & Smith, T. J. Leukoregulin upregulation of prostaglandin endoperoxide H synthase-2 expression in human orbital fibroblasts. Am J Physiol 277, C1075\u20131085 (1999).","journal-title":"Am J Physiol"},{"key":"BFsrep16672_CR57","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jbspin.2011.06.010","volume":"79","author":"WI Lea","year":"2012","unstructured":"Lea, W. I. & Lee, Y. H. The associations between interleukin-1 polymorphisms and susceptibility to ankylosing spondylitis: a meta-analysis. Joint Bone Spine 79, 370\u2013374 (2012).","journal-title":"Joint Bone Spine"},{"key":"BFsrep16672_CR58","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/ard.2003.007336","volume":"63","author":"CG Parks","year":"2004","unstructured":"Parks, C. G. et al. Systemic lupus erythematosus and genetic variation in the interleukin 1 gene cluster: a population based study in the southeastern United States. Ann Rheum Dis 63, 91\u201394 (2004).","journal-title":"Ann Rheum Dis"},{"key":"BFsrep16672_CR59","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/rheumatology\/keg443","volume":"43","author":"JS Ravindran","year":"2004","unstructured":"Ravindran, J. S. et al. Interleukin 1alpha, interleukin 1beta and interleukin 1 receptor gene polymorphisms in psoriatic arthritis. Rheumatology (Oxford) 43, 22\u201326 (2004).","journal-title":"Rheumatology (Oxford)"},{"key":"BFsrep16672_CR60","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s10067-006-0503-z","volume":"26","author":"G Alayli","year":"2007","unstructured":"Alayli, G. et al. T helper 1 type cytokines polymorphisms: association with susceptibility to Behcet\u2019s disease. Clin Rheumatol 26, 1299\u20131305 (2007).","journal-title":"Clin Rheumatol"},{"key":"BFsrep16672_CR61","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1126\/science.1135245","volume":"314","author":"RH Duerr","year":"2006","unstructured":"Duerr, R. H. et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314, 1461\u20131463 (2006).","journal-title":"Science"},{"key":"BFsrep16672_CR62","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/ard.2007.072819","volume":"67","author":"B Farago","year":"2008","unstructured":"Farago, B. et al. Functional variants of interleukin-23 receptor gene confer risk for rheumatoid arthritis but not for systemic sclerosis. Ann Rheum Dis 67, 248\u2013250 (2008).","journal-title":"Ann Rheum Dis"},{"key":"BFsrep16672_CR63","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0065-2776(08)60535-0","volume":"54","author":"WP Arend","year":"1993","unstructured":"Arend, W. P. Interleukin-1 receptor antagonist. Adv Immunol 54, 167\u2013227 (1993).","journal-title":"Adv Immunol"},{"key":"BFsrep16672_CR64","first-page":"449","volume":"81","author":"GH Tan","year":"1996","unstructured":"Tan, G. H., Dutton, C. M. & Bahn, R. S. Interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptor inhibit IL-1-induced glycosaminoglycan production in cultured human orbital fibroblasts from patients with Graves\u2019 ophthalmopathy. J Clin Endocrinol Metab 81, 449\u2013452 (1996).","journal-title":"J Clin Endocrinol Metab"},{"key":"BFsrep16672_CR65","first-page":"1018","volume":"38","author":"T Muhlberg","year":"1997","unstructured":"Muhlberg, T., Heberling, H. J., Joba, W., Schworm, H. D. & Heufelder, A. E. Detection and modulation of interleukin-1 receptor antagonist messenger ribonucleic acid and immunoreactivity in Graves\u2019 orbital fibroblasts. Invest Ophthalmol Vis Sci 38, 1018\u20131028 (1997).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFsrep16672_CR66","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1440-1711.1998.00757.x","volume":"76","author":"A Kelso","year":"1998","unstructured":"Kelso, A. Cytokines: principles and prospects. Immunol Cell Biol 76, 300\u2013317 (1998).","journal-title":"Immunol Cell Biol"},{"key":"BFsrep16672_CR67","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1365-2222.1995.tb00428.x","volume":"25","author":"LJ Rosenwasser","year":"1995","unstructured":"Rosenwasser, L. J. et al. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy 25 Suppl 2, 74\u201378; discussion 95\u201376 (1995).","journal-title":"Clin Exp Allergy"},{"key":"BFsrep16672_CR68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08830189809084486","volume":"17","author":"P Chomarat","year":"1998","unstructured":"Chomarat, P. & Banchereau, J. Interleukin-4 and interleukin-13: their similarities and discrepancies. Int Rev Immunol 17, 1\u201352 (1998).","journal-title":"Int Rev Immunol"},{"key":"BFsrep16672_CR69","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0167-5699(99)01492-9","volume":"21","author":"I Shirakawa","year":"2000","unstructured":"Shirakawa, I. et al. Atopy and asthma: genetic variants of IL-4 and IL-13 signalling. Immunol Today 21, 60\u201364 (2000).","journal-title":"Immunol Today"},{"key":"BFsrep16672_CR70","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1172\/JCI2629","volume":"102","author":"D Fishman","year":"1998","unstructured":"Fishman, D. et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102, 1369\u20131376 (1998).","journal-title":"J Clin Invest"},{"key":"BFsrep16672_CR71","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1089\/10799900050163253","volume":"20","author":"MM Jahromi","year":"2000","unstructured":"Jahromi, M. M., Millward, B. A. & Demaine, A. G. A polymorphism in the promoter region of the gene for interleukin-6 is associated with susceptibility to type 1 diabetes mellitus. J Interferon Cytokine Res 20, 885\u2013888 (2000).","journal-title":"J Interferon Cytokine Res"},{"key":"BFsrep16672_CR72","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/sj.gene.6363677","volume":"1","author":"M Pascual","year":"2000","unstructured":"Pascual, M. et al. IL-6 promoter polymorphisms in rheumatoid arthritis. Genes Immun 1, 338\u2013340 (2000).","journal-title":"Genes Immun"},{"key":"BFsrep16672_CR73","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/rheumatology\/40.6.656","volume":"40","author":"J Hulkkonen","year":"2001","unstructured":"Hulkkonen, J., Pertovaara, M., Antonen, J., Pasternack, A. & Hurme, M. Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjogren\u2019s syndrome and correlate with the clinical manifestations of the disease. Rheumatology (Oxford) 40, 656\u2013661 (2001).","journal-title":"Rheumatology (Oxford)"},{"key":"BFsrep16672_CR74","first-page":"1809","volume":"34","author":"M Lv","year":"2014","unstructured":"Lv, M. et al. [Role of Treg\/Th17 cells and related cytokines in Graves\u2019 ophthalmopathy]. Nan Fang Yi Ke Da Xue Xue Bao 34, 1809\u20131813 (2014).","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"BFsrep16672_CR75","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/ng.171","volume":"40","author":"NC Allen","year":"2008","unstructured":"Allen, N. C. et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet 40, 827\u2013834 (2008).","journal-title":"Nat Genet"},{"key":"BFsrep16672_CR76","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins, J. P. & Thompson, S. G. Quantifying heterogeneity in a meta-analysis. Stat Med 21, 1539\u20131558 (2002).","journal-title":"Stat Med"},{"key":"BFsrep16672_CR77","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins, J. P., Thompson, S. G., Deeks, J. J. & Altman, D. G. Measuring inconsistency in meta-analyses. BMJ 327, 557\u2013560 (2003).","journal-title":"BMJ"},{"key":"BFsrep16672_CR78","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.pu.09.050188.001011","volume":"9","author":"SJ Kuritz","year":"1988","unstructured":"Kuritz, S. J., Landis, J. R. & Koch, G. G. A general overview of Mantel-Haenszel methods: applications and recent developments. Annu Rev Public Health 9, 123\u2013160 (1988).","journal-title":"Annu Rev Public Health"},{"key":"BFsrep16672_CR79","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.1167\/iovs.14-15046","volume":"55","author":"SS Rong","year":"2014","unstructured":"Rong, S. S., Peng, Y., Liang, Y. B., Cao, D. & Jhanji, V. Does cigarette smoking alter the risk of pterygium? A systematic review and meta-analysis. Invest Ophthalmol Vis Sci 55, 6235\u20136243 (2014).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFsrep16672_CR80","doi-asserted-by":"crossref","first-page":"9497","DOI":"10.1038\/srep09497","volume":"5","author":"L Ma","year":"2015","unstructured":"Ma, L. et al. Association of PEDF polymorphisms with age-related macular degeneration and polypoidal choroidal vasculopathy: a systematic review and meta-analysis. Sci Rep 5, 9497 (2015).","journal-title":"Sci Rep"},{"key":"BFsrep16672_CR81","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jclinepi.2007.11.010","volume":"61","author":"JL Peters","year":"2008","unstructured":"Peters, J. L., Sutton, A. J., Jones, D. R., Abrams, K. R. & Rushton, L. Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol 61, 991\u2013996 (2008).","journal-title":"J Clin Epidemiol"},{"key":"BFsrep16672_CR82","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0895-4356(00)00242-0","volume":"53","author":"JA Sterne","year":"2000","unstructured":"Sterne, J. A., Gavaghan, D. & Egger, M. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol 53, 1119\u20131129 (2000).","journal-title":"J Clin Epidemiol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep16672.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep16672","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep16672.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T19:13:08Z","timestamp":1672945988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep16672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,18]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12,22]]}},"alternative-id":["BFsrep16672"],"URL":"https:\/\/doi.org\/10.1038\/srep16672","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,18]]},"assertion":[{"value":"1 July 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16672"}}